🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/10/2008 | 29,89 | 29,99 | 26,87 | 27,80 | -0,99% | 10,44% | 20.725.248 |
| 13/10/2008 | 25,98 | 28,43 | 25,88 | 28,07 | +12,16% | 9,81% | 21.405.819 |
| 10/10/2008 | 24,10 | 27,02 | 22,56 | 25,03 | +0,08% | 18,53% | 40.341.398 |
| 09/10/2008 | 27,15 | 27,26 | 24,36 | 25,01 | -8,10% | 10,69% | 26.672.124 |
| 08/10/2008 | 27,27 | 28,56 | 26,73 | 27,21 | -1,38% | 6,72% | 23.559.250 |
| 07/10/2008 | 28,66 | 29,81 | 27,50 | 27,60 | -3,73% | 8,06% | 21.661.531 |
| 06/10/2008 | 29,86 | 30,80 | 27,71 | 28,66 | -5,48% | 10,35% | 24.766.126 |
| 03/10/2008 | 29,95 | 30,82 | 29,82 | 30,32 | +2,19% | 3,34% | 18.125.684 |
| 02/10/2008 | 30,28 | 30,97 | 29,64 | 29,68 | -3,08% | 4,41% | 18.309.608 |
| 01/10/2008 | 29,98 | 30,95 | 29,96 | 30,62 | +1,68% | 3,31% | 14.831.191 |
| 30/09/2008 | 29,53 | 30,33 | 29,36 | 30,11 | +4,02% | 3,30% | 15.752.174 |
| 29/09/2008 | 30,43 | 30,65 | 28,95 | 28,95 | -5,54% | 5,58% | 25.067.846 |
| 26/09/2008 | 30,56 | 31,13 | 30,34 | 30,65 | -0,77% | 2,56% | 13.415.343 |
| 25/09/2008 | 30,18 | 31,14 | 30,08 | 30,89 | +2,86% | 3,51% | 16.323.648 |
| 24/09/2008 | 29,35 | 30,27 | 29,29 | 30,03 | +2,34% | 3,32% | 11.903.079 |
| 23/09/2008 | 30,03 | 30,53 | 29,28 | 29,34 | -2,23% | 4,16% | 18.463.454 |
| 22/09/2008 | 30,52 | 31,13 | 29,91 | 30,01 | -1,23% | 3,97% | 12.337.894 |
| 19/09/2008 | 31,15 | 31,36 | 29,12 | 30,38 | -0,28% | 7,20% | 26.693.294 |
| 18/09/2008 | 29,99 | 30,57 | 29,23 | 30,47 | +2,57% | 4,49% | 20.807.202 |
| 17/09/2008 | 30,31 | 30,73 | 29,57 | 29,70 | -3,56% | 3,81% | 23.541.853 |
| 16/09/2008 | 30,79 | 31,28 | 30,07 | 30,80 | -1,34% | 3,94% | 22.961.994 |
| 15/09/2008 | 31,59 | 32,30 | 31,21 | 31,22 | -3,25% | 3,44% | 16.216.123 |
| 12/09/2008 | 32,26 | 32,68 | 32,00 | 32,27 | -0,50% | 2,10% | 11.515.005 |
| 11/09/2008 | 31,60 | 32,54 | 31,60 | 32,43 | +1,40% | 2,96% | 17.416.607 |
| 10/09/2008 | 32,85 | 32,91 | 31,75 | 31,98 | -2,39% | 3,54% | 18.333.083 |
| 09/09/2008 | 33,87 | 34,21 | 32,74 | 32,77 | -3,21% | 4,34% | 15.416.290 |
| 08/09/2008 | 33,36 | 33,89 | 32,94 | 33,86 | +3,44% | 2,86% | 17.110.277 |
| 05/09/2008 | 32,31 | 32,80 | 32,05 | 32,73 | +0,38% | 2,30% | 16.092.774 |
| 04/09/2008 | 32,88 | 33,23 | 32,52 | 32,61 | -1,44% | 2,18% | 14.468.374 |
| 03/09/2008 | 33,21 | 33,27 | 32,50 | 33,08 | -0,46% | 2,33% | 9.457.781 |